Literature DB >> 12646017

Antiestrogens and selective estrogen receptor modulators as multifunctional medicines. 2. Clinical considerations and new agents.

V Craig Jordan1.   

Abstract

Mesh：

Substances：

Year:  2003        PMID： 12646017     DOI： 10.1021/jm020450x

Source DB:  PubMed          Journal:  J Med Chem        ISSN： 0022-2623            Impact factor:   7.446


× No keyword cloud information.
  55 in total

1.  Single and multiple ascending dose studies of a novel tissue-selective oestrogen receptor modulator, CHF 4227, in healthy postmenopausal women.

Authors:  Maurizio Civelli; Alessandro Piero Monici Preti; Valentina Cenacchi; Ivano Rondelli; Daniele Guastalla; Antoine Tarral; Philippe Dostert; Yann Guillevic; Marie-Claude Homery
Journal:  Br J Clin Pharmacol       Date:  2007-03-16       Impact factor: 4.335

2.  Ligand dissociation from estrogen receptor is mediated by receptor dimerization: evidence from molecular dynamics simulations.

Authors:  Milton T Sonoda; Leandro Martínez; Paul Webb; Munir S Skaf; Igor Polikarpov
Journal:  Mol Endocrinol       Date:  2008-04-10

3.  Towards a rational spacer design for bivalent inhibition of estrogen receptor.

Authors:  Alexander Bujotzek; Min Shan; Rainer Haag; Marcus Weber
Journal:  J Comput Aided Mol Des       Date:  2011-02-18       Impact factor: 3.686

4.  Linking estrogen-induced apoptosis with decreases in mortality following long-term adjuvant tamoxifen therapy.

Authors:  V Craig Jordan
Journal:  J Natl Cancer Inst       Date:  2014-09-30       Impact factor: 13.506

Review 5.  Tamoxifen regulation of sphingolipid metabolism--Therapeutic implications.

Authors:  Samy A F Morad; Myles C Cabot
Journal:  Biochim Biophys Acta       Date:  2015-05-09

Review 6.  New insights into the metabolism of tamoxifen and its role in the treatment and prevention of breast cancer.

Authors:  V Craig Jordan
Journal:  Steroids       Date:  2007-07-27       Impact factor: 2.668

7.  Bicyclic core estrogens as full antagonists: synthesis, biological evaluation and structure-activity relationships of estrogen receptor ligands based on bridged oxabicyclic core arylsulfonamides.

Authors:  Manghong Zhu; Chen Zhang; Jerome C Nwachukwu; Sathish Srinivasan; Valerie Cavett; Yangfan Zheng; Kathryn E Carlson; Chune Dong; John A Katzenellenbogen; Kendall W Nettles; Hai-Bing Zhou
Journal:  Org Biomol Chem       Date:  2012-11-21       Impact factor: 3.876

8.  Prediction of binding affinity for estrogen receptor alpha modulators using statistical learning approaches.

Authors:  Yonghua Wang; Yan Li; Jun Ding; Yuan Wang; Yaqing Chang
Journal:  Mol Divers       Date:  2008-07-26       Impact factor: 2.943

9.  2-Amino-7-oxo-4,5,6,7-tetra-hydro-1-benzothio-phene-3-carbonitrile.

Authors:  Mohamed Ziaulla; Afshan Banu; Noor Shahina Begum; Shridhar I Panchamukhi; I M Khazi
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2010-09-25

Review 10.  Minireview: role of orphan nuclear receptors in cancer and potential as drug targets.

Authors:  Stephen Safe; Un-Ho Jin; Erik Hedrick; Alexandra Reeder; Syng-Ook Lee
Journal:  Mol Endocrinol       Date:  2013-12-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.